Page 138 - 2021_10-Haematologica-web

L. Paschold et al.
458.
41. Bräuninger A, Küppers R, Spieker T, et al.
Molecular analysis of single B cells from T- cell-rich B-cell lymphoma shows the deri- vation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood. 1999;93(8):2679-2687.
42. Binder M, Léchenne B, Ummanni R, et al. Stereotypical chronic lymphocytic leukemia B-cell receptors recognize sur- vival promoting antigens on stromal cells. PLoS One. 2010;5(12):e15992.
43. Binder M, Müller F, Jackst A, et al. B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia. Cancer. 2011;117(9):1891-1900.
44. Binder M, Müller F, Frick M, et al. CLL B- cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLL. Blood. 2013;121(1):239-241.
45. Thurner L, Hartmann S, Fadle N, et al. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic tar- geting. Leukemia. 2019;33(1):148-158.
46. Thurner L, Preuss KD, Bewarder M, et al. Hyper-N-glycosylated SAMD14 and neura- bin-I as driver autoantigens of primary cen- tral nervous system lymphoma. Blood. 2018;132(26):2744-2753.
47.Borchmann S, Joffe E, Moskowitz CH, et al. Active surveillance for nodular lympho- cyte-predominant Hodgkin lymphoma. Blood. 2019;133(20):2121-2129.
48. Kenderian SS, Habermann TM, Macon WR, et al. Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lym- phoma: 40-year experience from a single institution. Blood. 2016;127(16):1960-1966.
2666
haematologica | 2021; 106(10)